DORIO, ANNALISA SUSANNA

DORIO, ANNALISA SUSANNA  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.025 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-gen-2016 Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D’Atri, S; Lacal, P Intervento a convegno
1-gen-2016 Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding Graziani, G; Ruffini, F; Tentori, L; Scimeca, M; Dorio, As; Atzori, Mg; Failla, C; Morea, V; Bonanno, E; D'Atri, S; Lacal, P Articolo su rivista
5-mag-2011 Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 Vernole, P; Muzi, A; Volpi, A; Terrinoni, A; Dorio, As; Tentori, L; Shah, G; Graziani, G Articolo su rivista
1-set-2008 Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide Lacal, Pm; Morea, V; Ruffini, F; Orecchia, A; Dorio, As; Failla, Cm; Soro, S; Tentori, L; Zambruno, G; Graziani, G; Tramontano, A; D'Atri, S Articolo su rivista
1-ago-2006 Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. Tentori, L; Leonetti, C; Scarsella, M; Muzi, A; Mazzon, E; Vergati, M; Forini, O; Lapidus, R; Xu, W; Dorio, As; Zhang, J; Cuzzocrea, S; Graziani, G Articolo su rivista
1-gen-2010 Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies Tentori, L; Dorio, As; Mazzon, E; Muzi, A; Saua, A; Cuzzocrea, S; Federici, G; Caccuri, Am; Graziani, G Intervento a convegno
1-gen-2008 Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. Dorio, As; Muzi, A; Lacal, P; Ruffini, F; Shah, G; Zhang, J; Tentori, L; Graziani, G Intervento a convegno
1-giu-2010 Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. Tentori, L; Muzi, A; Dorio, As; Scarsella, M; Leonetti, C; Shah, G; Xu, W; Camaioni, E; Gold, B; Pellicciari, R; Dantzer, F; Zhang, J; Graziani, G Articolo su rivista
1-mar-2009 Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells Lacal, Pm; Tentori, L; Muzi, A; Ruffini, F; Dorio, As; Xu, W; Arcelli, D; Zhang, J; Graziani, G Articolo su rivista
1-gen-2007 Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis Tentori, L; Lacal, P; Muzi, A; Dorio, As; Leonetti, C; Scarsella, M; Ruffini, F; Min, W; Stoppacciaro, A; Colarossi, C; Wang, Z; Zhang, J; Graziani, G Articolo su rivista
15-gen-2011 Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells D'Onofrio, G; Tramontano, F; Dorio, As; Muzi, A; Maselli, V; Fulgione, D; Graziani, G; Malanga, M; Quesada, P Articolo su rivista
15-mar-2010 Silenziamento vs inibizione farmacologica della poli (adp-ribosio) polimerasi-1 (parp-1): differenti effetti sulla chemio-sensibilità tumorale, in vivo ed in vitro Dorio, Annalisa Susanna Tesi di dottorato
1-giu-2008 Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity Tentori, L; Muzi, A; Dorio, As; Bultrini, S; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Navarra, P; Nocentini, G; Cuzzocrea, S; Graziani, G Articolo su rivista
1-gen-2008 Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. Tentori, L; Muzi, A; Dorio, As; Mazzon, E; Lacal, P; Shah, G; Zhang, J; Nocentini, G; Cuzzocrea, S; Graziani, G Intervento a convegno
1-gen-2007 Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors Muzi, A; Lacal, P; Dorio, As; Ruffini, F; Scarsella, M; Leonetti, C; Xu, W; Zhang, J; Tentori, L; Graziani, G Intervento a convegno
1-mag-2011 The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma Tentori, L; Dorio, As; Mazzon, E; Muzi, A; Sau, A; Cuzzocrea, S; Vernole, P; Federici, G; Caccuri, Am; Graziani, G Articolo su rivista
1-apr-2008 The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma Tentori, L; Dorio, As; Muzi, A; Lacal, Pm; Ruffini, F; Navarra, P; Graziani, G Articolo su rivista